Advertisement

Your questions answered

June 28, 2017

Your questions answered

We asked Michael Blaiss, MD, FACAAI, executive medical director, to share his thoughts on the results of the recent “pulse” survey and the College’s future direction under Vision 2020.

Q: Were you surprised by the results of the recent “pulse” survey?

A: No, it was not surprising to see that the issues that resonate most with the practicing allergist are advocacy and practice management.  Allergists are being bombarded with changes that are making it more and more difficult to keep their practice moving forward.

Advocacy is extremely important to allergists, especially related to the compounding issue and the uncertainty over health care reform in the U.S. Our Advocacy Council will continue to be the leader working to ensure the allergist’s voice is being heard in Washington D.C. and state capitols throughout the United States.

The College will put more resources into developing practice management programs and materials that address the needs of the practicing allergist. Presently, we are developing, with the Allergy and Asthma Network, an Allergist Payer Toolkit to help guide the allergist in dealing with prior authorization and step therapy.

Q: What stood out to you as a unique area for the College to focus on?

A: The College realizes we have to change with the changes in the demographics of the College membership. We had a very successful College Leadership Summit this spring. The plan is to continue this program over the coming years to get more of our younger members involved in active roles of leadership in the College. Our Annual Scientific Meeting will also evolve and change to better serve the needs of our membership. The College is putting more emphasis on our website with increased opportunities for education at our College Learning Connection. Social media will be expanded for internal communication with our members and external communication with the lay community. It is an ideal way to “market” the allergist to the patient population needing our services.

Advertisement